Sign In
Buy NVCR
$16.15
+0.330 (+2.09%)
At Close: Jun 03, 2026
Allergan announces FDA approval of Durysta for intracameral administration AGN
02:49pm, Thursday, 05'th Mar 2020
Allergan announces FDA approval of Durysta for intracameral administration AGN
Pros Holdings management to meet with RBC Capital PRO
02:48pm, Thursday, 05'th Mar 2020
Pros Holdings management to meet with RBC Capital PRO
Guidewire price target lowered to $120 from $140 at Needham GWRE
02:48pm, Thursday, 05'th Mar 2020
Guidewire price target lowered to $120 from $140 at Needham Needham GWRE
Cantel Medical falls -10.6% CMD
02:47pm, Thursday, 05'th Mar 2020
Cantel Medical falls -10.6% CMD
ProShares Trust Ultra VIX Short Term Futures ETF rises 13.1% UVXY
02:47pm, Thursday, 05'th Mar 2020
ProShares Trust Ultra VIX Short Term Futures ETF rises 13.1% UVXY
People's United management to meet with Piper Sandler PBCT
02:46pm, Thursday, 05'th Mar 2020
People's United management to meet with Piper Sandler PBCT
Cantel Medical trading resumes CMD
02:45pm, Thursday, 05'th Mar 2020
Cantel Medical trading resumes CMD
U.S. factory orders preview: orders are expected to tick up 0.1%
02:45pm, Thursday, 05'th Mar 2020
U.S. factory orders preview: orders are expected to tick up 0.1%
Monolithic Power management to meet with Oppenheimer MPWR
02:41pm, Thursday, 05'th Mar 2020
Monolithic Power management to meet with Oppenheimer MPWR
VectolQ Acquisition Corporation (Units) trading resumes
02:40pm, Thursday, 05'th Mar 2020
VectolQ Acquisition Corporation (Units) trading resumes
Novocure (NASDAQ:NVCR) Rating Lowered to Sell at BidaskClub
07:45am, Wednesday, 04'th Mar 2020
Novocure (NASDAQ:NVCR) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Wednesday, BidAskClub reports. NVCR has been the topic of severa
